Crossmark

Long-term outcome of randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR)

Crossref DOI link: https://doi.org/10.1007/s00345-023-04548-z

Published Online: 2023-08-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Garcia-Aparicio, Luis https://orcid.org/0000-0003-0744-562X
Martin-Sole, Oriol

Capdevila-Vilaro, Blanca

Perez-Bertolez, Sonia
License Information

Text and Data Mining valid from 2023-08-16

Version of Record valid from 2023-08-16
More Information

Article History

Received: 30 January 2023

Accepted: 23 July 2023

First Online: 16 August 2023

Declarations

:

: We have no conflict of interest.

: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by our Research Ethical Board NUMBER: 45-14 IRB (PIC-45-14).

: All patients included in the study signed the informed consent.

Document is current

Any future updates will be listed below